{"url_path":"/sec/jagx/8-k/2026-06-22/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K/A","doc_date":"2026-06-22","source_url":"https://www.sec.gov/Archives/edgar/data/1585608/0001193125-26-277570-index.html","accession_number":"0001193125-26-277570","cik":"0001585608","ticker":"JAGX","issuer_name":"Jaguar Health, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1585608/0001193125-26-277570-index.html","primary_entity_key":"0001585608","primary_entity_name":"Jaguar Health, Inc."},"word_count":86,"has_tables":true,"body_markdown":"Item 9.01\n\nFinancial Statements and Exhibits.\n\n(d) Exhibits.\n\n \n\nExhibit\nNo.\n\n  \n\nDescription\n\n99.1\n  \n[Press Release, dated June 22, 2026 (corrected)](d121487dex991.htm)\n\n104\n  \nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\nJAGUAR HEALTH, INC.\n\nBy:\n \n\n/s/ Lisa A. Conte\n\nName:\n \nLisa A. Conte\n\nTitle:\n \nPresident and Chief Executive Officer\n\nDate: June 22, 2026"}